List of Lexapro drug patents

Lexapro is owned by Allergan.

Lexapro contains Escitalopram Oxalate.

Lexapro has a total of 4 drug patents out of which 4 drug patents have expired.

Expired drug patents of Lexapro are:

  • US7420069
  • US6916941*PED
  • US7420069*PED
  • US6916941

Lexapro was authorised for market use on 14 August, 2002.

Lexapro is available in tablet;oral dosage forms.

The generics of Lexapro are possible to be released after 12 February, 2023.

LEXAPRO's oppositions filed in EPO
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US6916941 ALLERGAN Crystalline composition containing escitalopram
Aug, 2022

(9 months ago)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7420069 ALLERGAN Crystalline composition containing escitalopram
Aug, 2022

(9 months ago)

US6916941

(Pediatric)

ALLERGAN Crystalline composition containing escitalopram
Feb, 2023

(3 months ago)

US7420069

(Pediatric)

ALLERGAN Crystalline composition containing escitalopram
Feb, 2023

(3 months ago)

Do you want to check out LEXAPRO patents from before 2022?

Drugs and Companies using ESCITALOPRAM OXALATE ingredient

Market Authorisation Date: 14 August, 2002

Treatment: NA

Dosage: TABLET;ORAL

How can I launch a generic of LEXAPRO before it's patent expiration?
More Information on Dosage

LEXAPRO family patents

4

Denmark

4

Japan

3

United States

2

Croatia

2

Spain

2

Austria

2

Portugal

2

Germany

2

China

2

European Union

1

Colombia

1

Iceland

1

Australia

EA

1

EA

1

Israel

1

Egypt

1

Korea, Republic of

1

Canada

YU

1

Yugoslavia

1

New Zealand

1

Uruguay

1

Tunisia

1

Peru

1

Malaysia

1

ME

1

Bulgaria

1

Ukraine

1

Poland

1

Morocco

1

Norway

1

Hong Kong

1

Slovenia

1

Mexico

1

Argentina

1

Brazil

1

South Africa

1

Hungary

1

Turkey

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in